Long-term Outcome After Successful Catheter Ablation of Atrial Fibrillation
Overview
Authors
Affiliations
Background: Pulmonary vein isolation (PVI) is increasingly used for treatment of atrial fibrillation (AF), but few reports exist regarding long-term success. We determined 5-year outcomes of PVI among patients with freedom from AF off antiarrhythmic drugs (AAD) for 1 year after PVI.
Methods And Results: Consecutive patients with paroxysmal or persistent AF who underwent PVI at the University of Pennsylvania from 2000 to 2003 and were free from AF 1 year after ablation were included. Proximal isolation of PVs and non-PV triggers of AF was performed. Long-term ablation success, defined as freedom from AF off AAD after a single ablation procedure, was determined. All patients had transtelephonic monitoring at 3 to 6 months and 12 months and at least yearly contact thereafter. One hundred twenty-three patients were free of AF without AAD at 1 year. AF freedom off AAD was 85% at 3 years and 71% at 5 years, with an approximate 7% per year late recurrence rate after the first year. Patients with recurrent AF >or=5 years after index PVI were older, had larger left atrial size, more AF triggers and more likely had persistent AF. In multivariate analysis, persistent AF (odds ratio, 2.8; 95% confidence interval, 1.4 to 5.7, P=0.005) and age (odds ratio, 1.1; 95% confidence interval, 1.0 to 1.1, P=0.036) independently predicted long-term AF recurrence.
Conclusions: Among patients with paroxysmal or persistent AF and AF freedom 1 year after segmental PVI, the majority (71%) remained free of AF for up to 5 years, with an approximate late recurrence rate of 7% per year. Continued vigilance for recurrent AF after PV isolation is warranted, particularly in patients with persistent AF.
Duan S, Li X, Wang J, Wang Y, Xu T, Guo F Eur J Med Res. 2025; 30(1):39.
PMID: 39833853 PMC: 11748319. DOI: 10.1186/s40001-025-02286-z.
Monitoring and modulating cardiac bioelectricity: from Einthoven to end-user.
De Coster T, Nobacht A, Oostendorp T, de Vries A, Coronel R, Pijnappels D Europace. 2024; 27(1).
PMID: 39716965 PMC: 11711590. DOI: 10.1093/europace/euae300.
Wang Z, Wang B, Yang Y, Yang X, Che Y, Xia Y Front Cardiovasc Med. 2024; 11:1467585.
PMID: 39450235 PMC: 11499107. DOI: 10.3389/fcvm.2024.1467585.
Sanchez-Somonte P, Kittichamroen N, Gao-Kang J, Azizi Z, Alipour P, Kahykin Y JACC Adv. 2024; 3(9):101200.
PMID: 39247677 PMC: 11380002. DOI: 10.1016/j.jacadv.2024.101200.
Chatani R, Kubo S, Tasaka H, Sakata A, Yoshino M, Maruo T J Arrhythm. 2024; 40(4):879-890.
PMID: 39139871 PMC: 11317688. DOI: 10.1002/joa3.13073.